Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 43 (18) , 1465-1471
- https://doi.org/10.1016/0024-3205(88)90258-5
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Potentiation of central effects of L-dopa by an inhibitor of catechol-O-methyltransferaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- 3‐O‐Methyldopa and the response to levodopa in Parkinson's diseaseAnnals of Neurology, 1987
- High-Performance Liquid Chromato- Graphic Assay for Kinetic and Inhibition Properites of Monoamine Oxidase form AJournal of Liquid Chromatography, 1985
- The pharmacology of Parkinson's disease: Basic aspects and recent advancesCellular and Molecular Life Sciences, 1984
- The Cerebral Metabolism of L-DihydroxyphenylalaninePharmacology, 1984
- Simultaneous Determination of 3,4‐Dihydroxyphenylalanine, 5‐Hydroxytryptophan, Dopamine, 4‐Hydroxy‐3‐Methoxyphenylalanine, Norepinephrine, 3,4‐Dihydroxyphenylacetic Acid, Homovanillic Acid, Serotonin, and 5‐Hydroxyindoleacetic Acid in Rat Cerebrospinal Fluid and Brain by High‐Performance Liquid Chromatography with Electrochemical DetectionJournal of Neurochemistry, 1982
- Effect of a catechol-O-methyl transferase inhibitor, U-0521, with levodopa administrationBiochemical Pharmacology, 1979
- Variations in catechol-O-methyltransferase activity in inbred strains of ratsNeuropharmacology, 1977
- 3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrierLife Sciences, 1975
- Effect of chronic administration of L-dopa on catechol-O-methyltransferase in rat tissuesLife Sciences, 1973